Drawing for QUESTALPHA

USPTO serial 79292154

QUESTALPHA

Reviewed by CopyMark Law Group

Reg. 6932567Status 700Registered
Filing date
Status date
Registration date
Dec 27, 2022
Examiner
DONEGAN, DANIEL P
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with QUESTALPHA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Chemical products in the nature of artificial sponges for the absorption of fluids during surgical procedures in the fields of eye, ear and throat surgery and wound care for medical and hygienic purposes; medical plasters and wound dressings; wound dressings containing haemostatic agents; absorbent material for medical purposes, namely, absorbent swabs, pads, absorbent pads, absorbent plates and absorbent strips; viscose sponges for absorbing liquids of the human body, for medical purposes; absorbent material in the nature of wound dressings for covering wounds; viscose sponges for the application of liquid medicines as compresses and tampons; gauze for medical purposes; sponges for wound care; pharmaceutical wound preparations; medical adhesives as wound closure; antiseptic preparations for wound care; non-stick gels for use in wound drainage devices; absorbent sanitary pads; absorbent cotton wool for medical purposes; transdermal plasters; plasters with vitamin additives; plasters with integrated magnets for medical purposes; gauze for dressings; absorbent cotton for medical purposes; wound dressings for fixation purposes; dressing material for burns; dressings made of sterile plastic films for medical purposes; bandages for oral wounds; medical dressing materials, covering materials and applicators, namely, cotton wool and cotton sticks; moleskins for use as medical dressings; compresses for use as dressing material, for medical use; wound dressings; eye compresses; eye dressings for medical purposes; eye patches for medical purposes; adhesive tapes for medical bandages; foam medical dressings with adhesive edges; pharmaceutical agents for wound cleaning and irrigation; hydrocolloid dressings for medical purposes; alginate for pharmaceutical purposes; wound plasters; dressing materials and films for use in connection with vacuum pumps for medical purposes; gauze bandages for medical purposes; suction dressings for medical purposes; adhesive bandages for medical purposes; tape bandages for medical purposes; spray plasters and bandages for medical purposes; absorbing materials in the nature of cotton and irrigating pharmaceutical preparations for wound care for medical purposes; ear bandages for medical purposes; cotton for medical purposes; eye patches and eye pads for medical purposes; all of the foregoing for use in connection with surgical proceduresACTIVE—
010Surgical clips; wound suction devices; suture materials; wound drainage pouches; drainage tubes for medical purposes; medical devices, namely, surgical hooks; surgical and wound care equipment for wound closing and used in connection with artificial sponges for the absorption of fluids during surgical procedures in the fields of eye, ear and throat surgery and wound care; medical apparatus for wound drainage; subcutaneous needles for wound drainage; sutures for the temporary closure of wounds; medical instruments for closing wounds; surgical and wound treatment equipment; flap valves for medical drainage tubes; suction bags for medical purposes; suction bells for medical purposes; suction apparatus for medical purposes; suction bag holders for medical purposes; suction tubes for medical purposes; drape sheets made of absorbent cellulose wadding for use during surgery; medical pads for applying liquids to the skin, excluding dressing material; dispensers for medical dressing material; blood collection bags for medical purposes; orthopaedic kinesiology tapes; orthopaedic support bandages and braces; synthetic bandages for support purposes; elastic bandages; elastic bandages with copper and copper compounds; medical vacuum pumps with control unit for vacuum wound treatment and their parts and accessories, in particular transfer systems with disposable containers, tubes and star adapters; zinc paste bandages for medical purposes; plaster support bandages for orthopaedic purposes; cooling patches for medical purposes; umbilical belts; tubular support bandages; all of the foregoing to be used in connection with artificial sponges for the absorption of fluids during surgical procedures in the fields of eye, ear and throat surgery and wound careACTIVE—
042Research and consultancy in the field of medical techniques and laboratory techniques, which incorporate the use of artificial flow materials for the absorption of fluids during surgical procedures in the fields of eye, ear and throat surgery and wound care; scientific and technological services in the nature of research and design in the field of artificial flow materials for the absorption of fluids during surgical procedures in the fields of eye, ear and throat surgery and wound careACTIVE—
044Medical advice pertaining to the use of artificial flow materials for the absorption of fluids during surgical procedures in the fields of eye, ear and throat surgery and wound care; providing health care information by telephone to medical professionals; professional consultancy relating to health and health care; all aforesaid services excluding medical testing servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 1, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 6, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 6, 2023FIMPFINAL DISPOSITION PROCESSED—
Mar 27, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 27, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 27, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 29, 2022CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Nov 17, 2022LIMELIMITATION FROM THE IB - REQUEST EXAM REVIEW—
Nov 7, 2022LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Oct 16, 2022CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Oct 16, 2022LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Oct 11, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 11, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 10, 2022GPNXNOTIFICATION PROCESSED BY IB—
Sep 21, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 21, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Sep 21, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 10, 2022LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Sep 6, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 13, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jan 26, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 26, 2022OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 31, 2021CHLDCHANGE OF OWNER RECEIVED FROM IB—
Oct 13, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 12, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 12, 2021ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Apr 12, 2021GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 12, 2021GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 12, 2021CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 25, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 25, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 25, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 19, 2020RFNTREFUSAL PROCESSED BY IB—
Sep 25, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 25, 2020RFRRREFUSAL PROCESSED BY MPU—
Sep 3, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 2, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 25, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 21, 2020DOCKASSIGNED TO EXAMINER—
Aug 21, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 20, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance